Does Myo-Inositol Blood Glucose Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Myo-Inositol Blood Glucose Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - It is identified by increased glycated hemoglobin (HbA1c) or an abnormal oral glucose tolerance test. [Pérez-Piñero Silvia (2026); evidence level 2] - Subjects with prediabetes have a high risk of progressing to diabetes, with an annualized conversion rate of 5–10% []. [Pérez-Piñero Silvia (2026); evidence level 2] - The progression of prediabetes to overt T2DM is facilitated by well-known modifiable risk factors, particularly overweight and obesity, physical inactivity, high blood pressure, hyperlipidemia, poor dietary habits, smoking, and excessive alcohol consumption, which collectively contribute to insulin resistance and metabolic dysfunction [,,,]. [Pérez-Piñero Silvia (2026); evidence level 2] - 1 2 3 4 Prediabetes or intermediate hyperglycemia is characterized by elevated blood glucose levels above the normal range but not high enough to meet the criteria for the diagnosis of diabetes. [Pérez-Piñero Silvia (2026); evidence level 2] - 1 2 3 4 Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. [Muacevic Alexander (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.